capadenoson

Known as: 2-Amino-6-(((2-(4-Chlorophenyl)-1,3-Thiazol-4-Yl)Methyl)Sulfanyl)-4-(4-(2-Hydroxyethoxy)Phenyl)Pyridine-3,5-Dicarbonitrile 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2017
02420082017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The adenosine A2B receptor (A2BAR) has been identified as an important therapeutic target in cardiovascular disease, however in… (More)
  • table 2
  • table 3
  • table 5
Is this relevant?
2017
2017
Adenosine is known to be released under a variety of physiological and pathophysiological conditions to facilitate the protection… (More)
Is this relevant?
2016
2016
Adenosine A1 receptor (A1AR) stimulation is a powerful protective mechanism in cerebral and cardiac ischemia-reperfusion injury… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
We report the synthesis and biological evaluation of new derivatives of Capadenoson, a former drug candidate that was previously… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
2013
2013
BACKGROUND Adenosine elicits cardioprotection through A1-receptor activation. Therapy with adenosine A1-receptor agonists… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2012
2012
Anti-ischaemic effect of A1 adenosine receptor agonists was shown in animal and preclinical studies. The present proof-of-concept… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2011
2011
The release of the neurotransmitter norepinephrine (NE) is modulated by presynaptic adenosine receptors. In the present study we… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Review
2011
Review
2011
Medicinal chemical approaches have been applied to all four of the adenosine receptor (AR) subtypes (A(1), A(2A), A(2B), and A(3… (More)
Is this relevant?
2009
2009
Intense efforts of many pharmaceutical companies and academicians in the A1 adenosine receptor (AR) field have led to the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Review
2008
Review
2008
BACKGROUND The challenges in developing any A(1) adenosine receptor (A(1)-AdoR) agonist involve having the desired effect on… (More)
Is this relevant?